申请人:BRISTOL MYERS SQUIBB CO
                            
                            
                                公开号:WO2009137657A1
                            
                            
                                公开(公告)日:2009-11-12
                            
                            The disclosure provides compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their uses in inhibiting β-amyloid peptide ( β-AP) production.
                            该公开提供了I式化合物,包括药用可接受的盐,它们的药物组合物以及它们在抑制β-淀粉样肽(β-AP)产生中的用途。